Bioethics, Biosafety, IPR and Applications of Biotechnology in Odisha/India
This section covers bioethics, biosafety, intellectual property rights, and applications in Odisha and India. The exam tests ethical principles, biosafety levels, GMO regulation, patents, and local examples.
Core rules
Bioethics includes beneficence, non-maleficence, autonomy, and justice; informed consent and confidentiality are central. Biosafety levels range from BSL-1 for low-risk work to BSL-4 for dangerous pathogens. BSL-2 is used for moderate-risk agents. The Cartagena Protocol on Biosafety regulates transboundary movement of living modified organisms. In India, the Genetic Engineering Appraisal Committee (GEAC) under the Ministry of Environment, Forest and Climate Change approves GMO field trials and releases; the Recombinant DNA Advisory Committee and Institutional Biosafety Committees provide oversight. Patents protect inventions for 20 years; copyright protects expression; trademarks protect signs. The Budapest Treaty concerns deposit of microorganisms for patent procedure. Biopiracy is unauthorized use of biological resources or traditional knowledge. Odisha applications include rice and horticultural tissue culture, fisheries, biofertilizers, and health diagnostics; institutions such as ILS Bhubaneswar and OUAT contribute research.
Worked example
A researcher wants to field-test Bt brinjal. Because it is a genetically modified organism, institutional clearance alone is insufficient; GEAC approval is required at the national level. The reasoning is that field release has environmental and biosafety implications beyond the laboratory.
Traps that cost marks
A patent is not a copyright. BSL-2 is not for Ebola or other BSL-4 agents. Bioethics is not the same as biosafety. GEAC is not the same as the Institutional Biosafety Committee. Do not treat biopiracy as ordinary patent infringement.